NCT02898623 (MycoTB) is a clinical trial of No intervention in Active Tuberculosis, sponsored by University Hospital, Montpellier.

Who is sponsoring NCT02898623?

NCT02898623 is sponsored by University Hospital, Montpellier.

What drugs are being tested in NCT02898623?

Interventions in NCT02898623: No intervention.

What condition does NCT02898623 study?

NCT02898623 studies Active Tuberculosis.

Is NCT02898623 still recruiting?

NCT02898623 is currently terminated. Last updated 10 December 2021.

Last reviewed 2021-12-10 · How we verify

NCT02898623: MycoTB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Serological Test for the Diagnosis of TB

Terminated Last updated 10 December 2021

What this trial tests

trial testing No intervention in Active Tuberculosis in 1,000 participants. Terminated before completion.

Timeline

20 December 2013

Primary endpoint
20 December 2014

20 June 2015

Quick facts

Lead sponsor	University Hospital, Montpellier
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	20 December 2013
Primary completion	20 December 2014
Estimated completion	20 June 2015
Sites	1 location across France

Drugs / interventions tested

No intervention

Conditions studied

Active Tuberculosis — all drugs for Active Tuberculosis →

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Active Tuberculosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

TB remains a health problem in France with about 5,000 new cases per year. Development of new screening tests is a priority for TB. The main objective of the study is to evaluate performances of innovative blood tests to identify active tuberculosis in adults patients living in low-prevalence country. Adult patients with possible TB from will be tested for the presence of antibodies directed against M. tuberculosis selected antigens. Positive and negative predictive values will be established based on TB culture results.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Optimized Lysis-Extraction Method Combined With <i>IS6110</i>-Amplification for Detection of <i>Mycobacterium tuberculosis</i> in Paucibacillary Sputum Specimens.
Kolia-Diafouka P, Godreuil S, Bourdin A, Carrère-Kremer S, et al · · 2018 · cited 18× · PMID 30319564 · DOI 10.3389/fmicb.2018.02224
QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG.
Carrère-Kremer S, Kolia-Diafouka P, Pisoni A, Bolloré K, et al · · 2022 · cited 7× · PMID 35464936 · DOI 10.3389/fmicb.2022.825021

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Active Tuberculosis

Currently open trials in the same condition.

NCT05045391 — Pulmonary Aspergillosis in Tuberculosis Patients · active not recruiting
NCT06838780 — Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct · active not recruiting

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02898623 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 10 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02898623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing